文献速递妇科

超声引导高强度聚焦超声治疗腹壁子宫内膜异位症的回顾性研究

Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study.
PubMed 文献 · BJOG · 2017-01-01

该回顾性研究纳入2010年8月至2014年4月在中国某妇产科收治的32例腹壁子宫内膜异位症患者,采用超声引导高强度聚焦超声(USgHIFU)治疗。结果显示所有病灶均成功消融,治疗后6个月病灶体积和疼痛评分均较治疗前显著降低,无严重并发症。作者认为USgHIFU消融是治疗腹壁子宫内膜异位症安全有效的方法。

要点

  • 32例腹壁子宫内膜异位症患者接受USgHIFU治疗,所有病灶均成功消融。
  • 治疗后6个月病灶体积较治疗前显著缩小(2.80 ± 0.12 vs 1.33 ± 0.31 cm3)。
  • 治疗后6个月疼痛评分较治疗前显著降低(6.80 ± 2.64 vs 1.80 ± 0.3)。

核心结论

  • 基于本研究,USgHIFU消融是治疗腹壁子宫内膜异位症安全有效的方法。

研究设计与样本

  • 回顾性研究,纳入2010年8月至2014年4月在中国某妇产科收治的32例腹壁子宫内膜异位症患者,采用Model JC-200高强度聚焦超声肿瘤治疗系统进行USgHIFU治疗。

主要发现

  • 超声造影显示所有病灶均成功消融。
  • 治疗后6个月腹壁子宫内膜异位症病灶平均体积显著小于治疗前(2.80 ± 0.12 vs 1.33 ± 0.31 cm3)。
  • 治疗后6个月疼痛评分显著低于治疗前(6.80 ± 2.64 vs 1.80 ± 0.3)。
  • 治疗后即刻所有患者均测量无灌注体积(提示成功消融),范围为0.9至2.1 cm3(中位数1.6 cm3),消融分数范围为87%至100%(中位数94%)。
  • 患者出现局部水肿,仅持续1至3天;随访期间未发生严重并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for treating abdominal wall endometrioses (AWE). DESIGN: A retrospective study. SETTING: Department of Obstetrics and Gynaecology in China. POPULATION: Patients with abdominal wall endometriosis. METHODS: From August 2010 to April 2014, 32 patients with AWE were treated with USgHIFU in our hospital. USgHIFU treatment was performed with the Model JC-200 High Intensity Focused Ultrasound Tumor Therapeutic System. The symptom relief and the adverse effects were evaluated after USgHIFU ablation. MAIN OUTCOME MEASURES: USgHIFU as a new treatment option for patients with AWE. RESULTS: Contrast-enhanced ultrasound showed that all lesions were successfully ablated with USgHIFU. The follow-up results showed that the average volume of AWE lesions at 6 months after USgHIFU was significantly smaller than that before treatment (2.80 ± 0.12 versus 1.33 ± 0.31 cm3 ). The pain scores at 6 months after treatment were significantly lower than those before treatment (6.80 ± 2.64 versus 1.80 ± 0.3). The non-perfused volume (indicative of successful ablation) was measured in all patients immediately after treatment, ranging from 0.9 to 2.1 cm3 (median: 1.6 cm3 ), and the fractional ablation ranged from 87% to 100% (median: 94%). Local oedema was observed in these patients, lasting for 1-3 days only. No severe complications occurred during the follow-up period. CONCLUSIONS: Based on our study, USgHIFU ablation is a safe and effective method for treating AWE. TWEETABLE ABSTRACT: As a non-invasive treatment technique, HIFU could be used to treat abdominal wall endometriosis.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Luo S, Zhang C, Huang JP, et al. Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study. BJOG. 2017. PMID: 28856852. doi:10.1111/1471-0528.14741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。